DK1423708T3 - Sammensætninger og fremgangsmåder til bestemmelser af AA4RP - Google Patents

Sammensætninger og fremgangsmåder til bestemmelser af AA4RP

Info

Publication number
DK1423708T3
DK1423708T3 DK02781373T DK02781373T DK1423708T3 DK 1423708 T3 DK1423708 T3 DK 1423708T3 DK 02781373 T DK02781373 T DK 02781373T DK 02781373 T DK02781373 T DK 02781373T DK 1423708 T3 DK1423708 T3 DK 1423708T3
Authority
DK
Denmark
Prior art keywords
aa4rp
compositions
methods
relates
determination
Prior art date
Application number
DK02781373T
Other languages
English (en)
Inventor
Zouher Majd
Jamila Najib
Original Assignee
Genfit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0111598A external-priority patent/FR2829581A1/fr
Priority claimed from FR0210205A external-priority patent/FR2843395A1/fr
Application filed by Genfit filed Critical Genfit
Application granted granted Critical
Publication of DK1423708T3 publication Critical patent/DK1423708T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775—Apolipopeptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK02781373T 2001-09-07 2002-09-06 Sammensætninger og fremgangsmåder til bestemmelser af AA4RP DK1423708T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0111598A FR2829581A1 (fr) 2001-09-07 2001-09-07 Methodes de criblage de molecules utiles pour la prevention ou le traitement du syndrome metabolique, des maladies cardiovasculaires et de l'atherosclerose
FR0210205A FR2843395A1 (fr) 2002-08-12 2002-08-12 Composition et methodes pour le dosage de l'aa4rp
PCT/FR2002/003041 WO2003023408A1 (fr) 2001-09-07 2002-09-06 Compositions et methodes pour le dosage de l'aa4rp

Publications (1)

Publication Number Publication Date
DK1423708T3 true DK1423708T3 (da) 2007-04-02

Family

ID=26213176

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02781373T DK1423708T3 (da) 2001-09-07 2002-09-06 Sammensætninger og fremgangsmåder til bestemmelser af AA4RP

Country Status (10)

Country Link
US (1) US20040197823A1 (da)
EP (1) EP1423708B1 (da)
JP (1) JP2005502711A (da)
AT (1) ATE347108T1 (da)
CA (1) CA2459947A1 (da)
DE (1) DE60216482T2 (da)
DK (1) DK1423708T3 (da)
ES (1) ES2275924T3 (da)
IL (1) IL160531A0 (da)
WO (1) WO2003023408A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7972802B2 (en) * 2005-10-31 2011-07-05 University Of Washington Lipoprotein-associated markers for cardiovascular disease
US8241861B1 (en) 2008-07-08 2012-08-14 Insilicos, Llc Methods and compositions for diagnosis or prognosis of cardiovascular disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0976824A1 (en) * 1998-07-10 2000-02-02 Amsterdam Molecular Therapeutics Gene and protein involved in liver regeneration
US6455280B1 (en) * 1998-12-22 2002-09-24 Genset S.A. Methods and compositions for inhibiting neoplastic cell growth
JP2002539767A (ja) * 1998-12-22 2002-11-26 ジェンセット シグナルペプチドを含む相補的ｄｎａのコードタンパク質
ATE364628T1 (de) * 1999-03-08 2007-07-15 Genentech Inc Verfahren und zusammensetzungen zur diagnose von tumoren
CA2368098A1 (en) * 1999-06-25 2001-01-04 Genset S.A. Complementary dna's encoding proteins with signal peptides
CA2311201A1 (en) * 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins
AU2001253620A1 (en) * 2000-04-14 2001-10-30 Nuvelo, Inc. Materials and methods relating to lipid metabolism

Also Published As

Publication number Publication date
ES2275924T3 (es) 2007-06-16
IL160531A0 (en) 2004-07-25
US20040197823A1 (en) 2004-10-07
JP2005502711A (ja) 2005-01-27
DE60216482D1 (de) 2007-01-11
EP1423708A1 (fr) 2004-06-02
ATE347108T1 (de) 2006-12-15
WO2003023408A1 (fr) 2003-03-20
EP1423708B1 (fr) 2006-11-29
CA2459947A1 (fr) 2003-03-20
DE60216482T2 (de) 2007-08-23

Similar Documents

Publication Publication Date Title
EP1379693A4 (en) BIO STICK CODES BASED ON OLIGONUCLEOTIDE-MODIFIED PARTICLES
WO2003043487A3 (en) Method of using a non-antibody protein to detect and measure an analyte
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
DK0820522T3 (da) Assays og indretninger til detektering af ekstrahepatisk galdeatresi
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
DK1513878T3 (da) Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100
WO2003064993A3 (en) Methods and materials for detecting genetic material
DK1098658T3 (da) Manipulerede proteiner til detektering af analytter
WO2003016527A3 (en) Process for the detection of oxidative stress and kit for its implementation
EP1687283A4 (en) PROCESS AND COMPOSITION FOR DETERMINING FK 506
DE60228557D1 (de) Candida-nachweis
WO2003106964A3 (en) HIGH EFFICIENCY METHODS AND DEVICES FOR ASSAYING ANALYTES IN A FLUID SAMPLE
DK1639130T3 (da) Prober, biblioteker og kits til analyse af blandinger af nukleinsyrer og metoder til opbygning af disse
ATE408829T1 (de) Verfahren und assaykits zum nachweis mononuklearer zellphänotypen
CY1107621T1 (el) Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα
WO2007001737A3 (en) Methods and compositions for detecting herpes simplex virus type 2
WO2006004958A3 (en) Detection or measurement of antibodies to antigenic proteins in biological tissues or samples
ATE333091T1 (de) Verfahren zur messung von blutersatzstoffen
DE60228952D1 (de) Nachweis von Legionella durch ein PCR und FRET verwendendes Verfahren
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
DE602004011228D1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
DK1386160T3 (da) Fremgangsmåde til påvisning af blodcelle-antigener og antistoffer rettet mod disse
DK1423708T3 (da) Sammensætninger og fremgangsmåder til bestemmelser af AA4RP
DK1057021T3 (da) Fremgangsmåde til måling af totalanalyt
DE602004031571D1 (de) Enzymhemmungsimmunverfahren